Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3Radiation Pneumonitis 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Brain Neoplasms 1Adenocarcinoma of Lung 1

Interventions

nintedanib 2durvalumab 1beclomethasone 17-monopropionate 1aumolertinib 1apatinib 1Radiotherapy 1Prednisone 1Nicorandil 1Immunotherapy 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Enalapril 1Disulfides 1Dexamethasone 1Angiogenesis Inhibitors 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Radiation Pneumonitis × Angiogenesis Inhibitors × Clear all
NCT06700421 2024-11-22

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Chongqing University Cancer Hospital

Phase 2 Active not recruiting
32 enrolled

Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡